Literature DB >> 861090

Transmural myocardial infarction in young women taking oral contraceptives. Evidence of reduced regional coronary flow in spite of normal coronary arteries.

H J Engel, H Hundeshagen, P Lichtlen.   

Abstract

A normal coronary arteriogram after transmural myocardial infarction is a well-recognised phenomenon, but the pathophysiology remains unclear in most cases. A possible aetiological role of oral contraceptives is suggested by the occurrence of unequivocal myocardial infarction with normal or near normal coronary arteries in 4 young women who had been taking oral contraceptives. While the cause-effect relation of coronary thrombosis and myocardial infarction remains controversial in patients with coronary atherosclerosis, a primary occlusion of macroscopically normal coronary arteries by cellular elements of blood appears possible in these cases. The action of contraceptives, the, would be analogous to their thrombogenic effect in peripheral veins and cerebral arteries. Absence of atherosclerotic lesions in these patients favours spontaneous thrombolysis and restoration of normal vessel patency in many of these cases. Myocardial blood flow in the region of the damaged left ventricular wall remains low in spite of normal coronary arteries. Reduced perfusion in infarcted areas is assumed to be the consequence of structural and functional alterations at precapillary and capillary level rather than an effect of obstructive coronary disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861090      PMCID: PMC483263          DOI: 10.1136/hrt.39.5.477

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  29 in total

1.  Quantitative scintigraphic display of myocardial blood flow. Technique and clinical evaluation.

Authors:  H Hundeshagen; S Geisler; P Dittmann; P Lichtlen; H J Engel
Journal:  Eur J Nucl Med       Date:  1976

2.  MEASUREMENT OF MYOCARDIAL BLOOD FLOW IN ANIMALS AND MAN BY SELECTIVE INJECTION OF RADIOACTIVE INERT GAS INTO THE CORONARY ARTERIES.

Authors:  R S ROSS; K UEDA; P R LICHTLEN; J R REES
Journal:  Circ Res       Date:  1964-07       Impact factor: 17.367

3.  COMPLICATIONS OF ORAL CONTRACEPTION.

Authors:  F HARTVEIT
Journal:  Br Med J       Date:  1965-01-02

4.  ORAL CONTRACEPTIVES AND CORONARY THROMBOSIS.

Authors:  J H NAYSMITH
Journal:  Br Med J       Date:  1965-01-23

5.  ORAL CONTRACEPTION AND THROMBOSIS.

Authors:  G R OSBORN
Journal:  Br Med J       Date:  1965-04-24

6.  Regional myocardial blood flow in patients with residual anterior and inferior transmural infarction.

Authors:  E M Dwyer; R B Dell; P J Cannon
Journal:  Circulation       Date:  1973-11       Impact factor: 29.690

7.  Myocardial infarction and oral contraceptive agents.

Authors:  E B Waxler; D Kimbiris; H Van den Broek; B L Segal; W Likoff
Journal:  Am J Cardiol       Date:  1971-07       Impact factor: 2.778

8.  Vascular lesions in women taking oral contraceptives.

Authors:  N S Irey; W C Manion; H B Taylor
Journal:  Arch Pathol       Date:  1970-01

9.  Myocardial infarction in young women with normal coronary arteriograms.

Authors:  D L Glancy; M L Marcus; S E Epstein
Journal:  Circulation       Date:  1971-10       Impact factor: 29.690

10.  Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report.

Authors:  M P Vessey; R Doll
Journal:  Br Med J       Date:  1969-06-14
View more
  5 in total

Review 1.  Hormonal steroid contraceptives: a further review of adverse reactions.

Authors:  E G McQueen
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

2.  Management of myocardial infarction in young women.

Authors: 
Journal:  Br Med J       Date:  1977-11-26

3.  Assessment of regional myocardial blood flow using the inert gas washout technique.

Authors:  P R Lichtlen; H J Engel
Journal:  Cardiovasc Radiol       Date:  1979-09

Review 4.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

5.  Therapeutic options for premature coronary artery disease.

Authors:  Ameen F Person; Cam Patterson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.